Candidate gene
| potentialy target for the treatment of prostate cancer |
|
IGFBP2 inhibition may be an advantageous clinical approach to ablate the most malignant cancer cells in glioblastoma without off-target effects on normal cells |
Marker
| a high circulating level of IGFBP2 is significantly associated with poor survival, suggesting that blood IGFBP2 levels could be a prognostic biomarker for lung cancer |
|
may be a useful biomarker integrating the nutritional status, as well as the biological effects of GH, IGF1, and insulin |
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | brain | | |
marker and potential therapeutic target for CDKN2A-deleted gliomas | neurosensorial | visual | anterior chamber | |
can be a therapeutic candidate for corneal antifibrotic strategy |
| |